Zelis Announces 30-Year Healthcare Technology Veteran, R. Andrew Eckert, as New Chief Executive Officer

BEDMINSTER, N.J.–(BUSINESS WIRE)–#GPTWcertified–Zelis, the industry’s leading claims cost and payments optimization platform with proprietary technology and solutions to price, pay and explain healthcare claims, announced that R. Andrew Eckert has joined the company as its new Chief Executive Officer. A 30-year veteran of the healthcare technology industry, Eckert has had a lifelong focus on enabling healthcare innovation and leading strong teams to their full potential.


During his career, Eckert has served as CEO of some of the healthcare industry’s most notable and impactful healthcare technology companies, including TriZetto Corporation, Eclipsys Corporation, and Valence Health. In each case, Eckert helped deliver client success, product and technology innovation and strong growth. Immediately prior to joining Zelis, Eckert was the CEO of Acelity, a global advanced wound care company which was sold to 3M in October 2019. Earlier in his career, Eckert served as CEO of CRC Health Group, a leading behavioral health provider owned by Bain Capital, and SumTotal Systems, a leading education technology software company.

Eckert serves on the Board of Directors of Becton Dickinson, a medical technology company, and as Chair of the Board of Directors of Varian Medical Systems, a radiation oncology treatments and software company.

“Zelis’ mission is to optimize the healthcare payments cycle – which we define as pricing, paying and explaining the claim – on behalf of payors, providers and consumers. Andy’s deep experience leading multiple companies that serve Zelis’ core constituencies, combined with his track record of driving outstanding client success, makes him a terrific choice to lead Zelis going forward,” said Dave Ament, Managing Partner of Parthenon Capital.

“I am delighted that Andy is joining Zelis,” said Devin O’Reilly, Managing Director, Bain Capital. “Andy is a highly seasoned CEO and he will help position the company to grow, innovate, and transform our industry.”

“I’m thrilled to be joining Zelis. We are a heavyweight in healthcare technology and are at the epicenter of solving some of the industry’s most intractable challenges. I believe our company will continue to make a huge impact in making the U.S. healthcare system more understandable and affordable,” said Eckert. “I look forward to further building and strengthening the company’s momentum in serving our clients with innovative solutions.”

About Zelis

Zelis is the healthcare industry’s leading claims cost and payments optimization platform with superior technology and solutions to price claims, pay claims and explain claims, all at enterprise scale on a claim-by-claim basis. Zelis leverages proprietary technology, robust analytics, extensive payment and provider networks, and innovative claim savings channels to deliver to the industry superior administrative and medical cost savings. Zelis was founded on a belief that there is a “better way” to determine the cost of a healthcare claim, manage payment related data, and make the claim payment. Zelis provides the industry’s only comprehensive, integrated platform to take a claim through the entire pre-payment to payments lifecycle. Zelis’ ~1000 associates serve more than 700 payor clients, including the top-5 national health plans, Blues plans, regional health plans, TPAs and self-insured employers, and more than 1.5 million providers. Zelis delivers more than $5B of claims savings, $50B of provider payments and 500 million payment data communications annually, and enjoys a highly recurring revenue model and a strong margin profile.

Contacts

Thuy-An Wilkins

Zelis

908.389.8756

Thuy-An.Wilkins@zelis.com

Staff

Recent Posts

Bulletin from the 2024 Annual General Meeting of PMD

STOCKHOLM, SWEDEN / ACCESSWIRE / June 28, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The Annual…

33 mins ago

Waystar announces term loan repricing and credit rating upgrades from Fitch, Moody’s, and S&P Global

Reduces Waystar's cost of capital and enhances its ability to allocate free cash flow towards…

13 hours ago

NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT

HOUSTON, June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:…

13 hours ago

Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing Technology

License provides exclusive access to innovative epigenetic editors and expands the reach of Chroma's platform…

13 hours ago

Pulmonary Fibrosis Foundation’s 2024 PFF Walk Raises Funds Toward a Cure

Nationwide Walk Series Kicks Off July 20 in Pittsburgh CHICAGO, June 27, 2024 /PRNewswire/ --…

13 hours ago